See more : Ashland Inc. (ASH) Income Statement Analysis – Financial Results
Complete financial analysis of Bausch Health Companies Inc. (BHC.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bausch Health Companies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Fortinet, Inc. (FTNT) Income Statement Analysis – Financial Results
- Nordea Invest Nordic Small Cap (NDINSCKL1.CO) Income Statement Analysis – Financial Results
- PC Partner Group Limited (1263.HK) Income Statement Analysis – Financial Results
- IReader Technology Co., Ltd. (603533.SS) Income Statement Analysis – Financial Results
- Manbro Industries Limited (MANBRO.BO) Income Statement Analysis – Financial Results
Bausch Health Companies Inc. (BHC.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bauschhealth.com
About Bausch Health Companies Inc.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.76B | 8.12B | 8.43B | 8.03B | 8.60B | 8.38B | 8.72B | 9.67B | 10.50B | 8.26B | 5.77B | 3.55B | 2.46B | 1.18B | 820.43M | 757.18M | 842.82M | 1.07B | 935.54M | 886.54M | 823.72M | 788.03M | 583.26M | 309.17M | 176.50M | 112.80M | 82.40M | 66.40M | 20.60M | 17.30M | 11.10M |
| Cost of Revenue | 2.56B | 2.36B | 2.39B | 2.25B | 2.35B | 2.35B | 2.55B | 2.61B | 2.65B | 2.25B | 1.91B | 1.04B | 726.83M | 405.75M | 325.09M | 197.17M | 223.68M | 223.27M | 206.82M | 229.53M | 139.46M | 164.71M | 126.00M | 68.03M | 28.20M | 23.60M | 27.70M | 23.20M | 4.20M | 4.30M | 2.10M |
| Gross Profit | 6.20B | 5.76B | 6.04B | 5.78B | 6.25B | 6.03B | 6.18B | 7.06B | 7.85B | 6.01B | 3.86B | 2.51B | 1.74B | 775.49M | 495.34M | 560.01M | 619.14M | 847.21M | 728.72M | 657.02M | 684.27M | 623.32M | 457.27M | 241.14M | 148.30M | 89.20M | 54.70M | 43.20M | 16.40M | 13.00M | 9.00M |
| Gross Profit Ratio | 70.78% | 70.90% | 71.61% | 71.98% | 72.68% | 71.95% | 70.79% | 73.01% | 74.81% | 72.72% | 66.98% | 70.72% | 70.50% | 65.65% | 60.38% | 73.96% | 73.46% | 79.14% | 77.89% | 74.11% | 83.07% | 79.10% | 78.40% | 78.00% | 84.02% | 79.08% | 66.38% | 65.06% | 79.61% | 75.14% | 81.08% |
| Research & Development | 604.00M | 529.00M | 465.00M | 452.00M | 471.00M | 414.00M | 366.00M | 455.00M | 582.80M | 246.00M | 156.78M | 268.95M | 174.89M | 157.56M | 120.78M | 92.84M | 118.12M | 95.47M | 88.88M | 72.50M | 86.57M | 52.15M | 51.02M | 52.66M | 33.10M | 17.50M | 0.00 | 7.50M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.27B | 2.11B | 2.11B | 1.92B | 2.01B | 1.99B | 2.12B | 2.25B | 2.03B | 1.59B | 1.03B | 812.86M | 584.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 625.00M | 518.00M | 515.00M | 451.00M | 544.00M | 481.00M | 462.00M | 564.00M | 652.00M | 435.00M | 277.00M | 157.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.92B | 2.63B | 2.62B | 2.37B | 2.55B | 2.47B | 2.58B | 2.81B | 2.68B | 2.03B | 1.31B | 812.86M | 584.31M | 329.16M | 190.39M | 188.92M | 161.00M | 238.43M | 231.11M | 274.55M | 242.77M | 165.70M | 110.10M | 58.09M | 29.60M | 17.60M | 14.00M | 10.20M | 12.60M | 9.30M | 8.50M |
| Other Expenses | 1.71B | 1.25B | 1.75B | 1.65B | 3.31B | 21.00M | -1.00M | -73.00M | -256.10M | 268.70M | -234.44M | 19.72M | 546.83M | 219.76M | 104.73M | 83.93M | 151.34M | 268.64M | 234.65M | 203.77M | 213.27M | 103.44M | 44.51M | 0.00 | 10.10M | 5.00M | 3.20M | 2.00M | 1.20M | 800.00K | 700.00K |
| Operating Expenses | 5.24B | 4.40B | 4.84B | 4.46B | 6.34B | 5.53B | 5.64B | 5.94B | 5.67B | 3.82B | 3.36B | 2.01B | 1.31B | 706.47M | 295.12M | 365.70M | 430.46M | 602.55M | 554.64M | 550.83M | 542.61M | 321.29M | 205.63M | 110.75M | 72.80M | 40.10M | 17.20M | 19.70M | 13.80M | 10.10M | 9.20M |
| Cost & Expenses | 7.79B | 6.77B | 7.23B | 6.71B | 8.69B | 7.88B | 8.19B | 8.55B | 8.31B | 6.08B | 5.27B | 3.05B | 2.03B | 1.11B | 620.21M | 562.87M | 654.14M | 825.82M | 761.46M | 780.35M | 682.07M | 486.00M | 331.63M | 178.78M | 101.00M | 63.70M | 44.90M | 42.90M | 18.00M | 14.40M | 11.30M |
| Interest Income | 26.00M | 14.00M | 7.00M | 13.00M | 12.00M | 11.00M | 12.00M | 8.00M | 3.30M | 5.00M | 8.02M | 5.99M | 4.08M | 1.29M | 1.12M | 9.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.33B | 1.46B | 1.43B | 1.53B | 1.61B | 1.69B | 1.84B | 1.84B | 1.56B | 971.00M | 844.32M | 473.40M | 330.44M | 84.31M | 25.42M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.26B | 1.39B | 1.55B | 1.83B | 1.90B | 2.64B | 2.86B | 2.67B | 2.40B | 1.55B | 1.90B | 928.89M | 557.81M | 219.76M | 149.26M | 103.43M | 100.77M | 107.87M | 205.41M | 194.64M | 166.85M | 89.96M | 67.87M | 21.53M | 10.10M | 5.00M | 3.20M | 2.00M | 1.20M | 800.00K | 700.00K |
| EBITDA | 2.20B | 2.88B | 3.26B | 3.14B | 1.85B | 350.00M | 3.41B | 2.27B | 5.11B | 3.91B | 1.55B | 1.07B | 929.13M | 102.55M | 349.10M | 230.83M | 289.45M | 349.73M | 440.79M | 323.60M | 272.27M | 391.99M | 319.50M | 151.92M | 85.60M | 54.10M | 40.70M | 25.50M | 3.81M | 3.56M | 500.00K |
| EBITDA Ratio | 25.15% | 31.82% | 30.65% | 31.37% | 21.21% | 37.88% | 39.05% | 56.41% | 48.43% | 50.01% | 54.54% | 52.50% | 40.12% | 43.26% | 42.73% | 53.47% | 45.68% | 54.23% | 50.90% | 39.06% | 63.19% | 74.65% | 74.56% | 116.55% | 48.33% | 47.96% | 49.39% | 38.40% | 0.97% | -22.54% | -46.85% |
| Operating Income | 963.00M | 1.37B | 1.21B | 676.00M | -73.00M | -2.38B | 102.00M | -566.00M | 1.55B | 2.04B | -409.50M | 79.69M | 299.96M | -110.09M | 181.15M | 124.11M | 188.01M | 229.53M | 154.27M | 106.19M | 16.94M | 134.28M | 251.64M | 130.39M | 75.50M | 49.10M | 37.50M | 23.50M | 2.60M | 2.90M | -200.00K |
| Operating Income Ratio | 11.00% | 16.86% | 14.35% | 8.42% | -0.85% | -28.45% | 1.17% | -5.85% | 14.81% | 24.68% | -7.10% | 2.25% | 12.18% | -9.32% | 22.08% | 16.39% | 22.31% | 21.44% | 16.49% | 11.98% | 2.06% | 17.04% | 43.14% | 42.17% | 42.78% | 43.53% | 45.51% | 35.39% | 12.62% | 16.76% | -1.80% |
| Total Other Income/Expenses | -1.35B | -583.00M | -1.47B | -1.61B | -1.63B | -1.77B | -1.84B | -1.87B | -1.68B | -947.00M | -904.90M | -1.20B | -317.96M | -126.18M | -6.20M | 2.80M | 20.73M | -8.89M | -33.71M | -46.12M | -49.14M | -24.99M | -148.91M | -205.47M | -8.80M | -1.70M | -400.00K | -100.00K | 3.52M | 7.13M | 4.30M |
| Income Before Tax | -390.00M | -129.00M | -1.02B | -934.00M | -1.84B | -4.15B | -1.74B | -2.44B | -128.10M | 1.09B | -1.31B | -394.23M | -18.00M | -236.26M | 174.96M | 126.90M | 208.74M | 222.29M | 122.15M | 61.70M | -31.27M | 109.30M | 102.73M | -75.08M | 66.70M | 47.40M | 37.10M | 23.40M | 6.10M | 9.90M | 4.10M |
| Income Before Tax Ratio | -4.45% | -1.59% | -12.14% | -11.64% | -21.36% | -49.57% | -19.96% | -25.17% | -1.22% | 13.22% | -22.78% | -11.12% | -0.73% | -20.00% | 21.32% | 16.76% | 24.77% | 20.77% | 13.06% | 6.96% | -3.80% | 13.87% | 17.61% | -24.28% | 37.79% | 42.02% | 45.02% | 35.24% | 29.61% | 57.23% | 36.94% |
| Income Tax Expense | 221.00M | 83.00M | -87.00M | -375.00M | -54.00M | -10.00M | -4.15B | -27.00M | 134.20M | 180.40M | -450.78M | -278.20M | -177.56M | -28.07M | -1.50M | -73.00M | 13.20M | 14.50M | 22.55M | 8.95M | -4.00M | 21.50M | 15.29M | 9.36M | 4.20M | 2.00M | 1.90M | 700.00K | 200.00K | 400.00K | 200.00K |
| Net Income | -592.00M | -212.00M | -937.00M | -559.00M | -1.78B | -4.15B | 2.40B | -2.41B | -266.20M | 913.50M | -866.14M | -116.03M | 159.56M | -208.19M | 176.46M | 199.90M | 195.54M | 203.94M | 89.03M | 52.75M | -27.27M | 87.80M | 87.45M | -147.98M | 62.50M | 45.40M | 35.20M | 22.70M | 5.90M | 9.50M | 3.90M |
| Net Income Ratio | -6.76% | -2.61% | -11.11% | -6.96% | -20.73% | -49.50% | 27.56% | -24.90% | -2.54% | 11.05% | -15.01% | -3.27% | 6.48% | -17.62% | 21.51% | 26.40% | 23.20% | 19.05% | 9.52% | 5.95% | -3.31% | 11.14% | 14.99% | -47.86% | 35.41% | 40.25% | 42.72% | 34.19% | 28.64% | 54.91% | 35.14% |
| EPS | -1.62 | -0.59 | -2.61 | -1.58 | -5.07 | -11.86 | 8.63 | -6.94 | -0.78 | 3.16 | -2.70 | -0.38 | 0.53 | -1.06 | 1.16 | 1.52 | 1.21 | 1.54 | 1.79 | 1.20 | -0.17 | 0.91 | 1.02 | -1.15 | 0.72 | 0.65 | 0.50 | 0.32 | 0.08 | 0.16 | -0.05 |
| EPS Diluted | -1.62 | -0.58 | -2.61 | -1.57 | -5.06 | -11.86 | 8.59 | -6.94 | -0.77 | 3.10 | -2.70 | -0.38 | 0.50 | -1.06 | 1.16 | 1.52 | 1.21 | 1.54 | 1.79 | 1.20 | -0.17 | 0.87 | 0.92 | -1.03 | 0.68 | 0.65 | 0.50 | 0.32 | 0.08 | 0.16 | -0.05 |
| Weighted Avg Shares Out | 364.90M | 362.00M | 358.90M | 354.43M | 351.97M | 349.87M | 350.20M | 347.12M | 342.70M | 335.40M | 320.78M | 305.26M | 304.66M | 195.81M | 158.24M | 159.73M | 160.84M | 160.06M | 159.43M | 160.99M | 158.43M | 151.96M | 136.93M | 128.82M | 102.54M | 106.56M | 100.57M | 98.70M | 100.00M | 83.13M | 89.12M |
| Weighted Avg Shares Out (Dil) | 364.90M | 362.90M | 358.90M | 355.00M | 352.10M | 349.87M | 351.80M | 347.30M | 347.30M | 341.50M | 321.00M | 305.45M | 326.12M | 195.81M | 158.51M | 159.73M | 160.88M | 160.08M | 159.68M | 160.99M | 160.12M | 160.46M | 150.69M | 143.51M | 108.17M | 106.56M | 100.57M | 98.70M | 100.00M | 83.13M | 89.12M |
Source: https://incomestatements.info
Category: Stock Reports